MedPath
HSA Approval

PEACEF SYRUP 30 mg/5 ml

SIN11124P

PEACEF SYRUP 30 mg/5 ml

PEACEF SYRUP 30 mg/5 ml

September 25, 1999

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R01BA52

pseudoephedrine, combinations

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

PSEUDOEPHEDRINE HCl

30 mg/5 ml

Pseudoephedrine

TRIPROLIDINE HCl

1.25 mg/5 ml

Triprolidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PEACEF SYRUP 30 mg/5 ml - HSA Approval | MedPath